Referenser

  1. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483-94.
  2. Ballardini N, Kull I, Lind T, Hallner E, Almqvist C, Ostblom E, et al.. Development and comorbidity of eczema, asthma and rhinitis to age 12: data from the BAMSE birth cohort. Allergy. 2012;67(4):537-44.
  3. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-22.. Lancet;2016:1109-22.
  4. Williams H, Bigby M, Herxheimer A, Naldi.. Evidence-Based Dermatology. 3rd Edition. John Wiley & Sons; 2014.
  5. Broeders JA, Ahmed Ali U, Fischer G. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. J Am Acad Dermatol. 2016;75(2):410-9.e3.
  6. Hong E, Smith S, Fischer G. Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients. Pediatr Dermatol. 2011;28(4):393-6.. Pediatr Dermatol;2011: Pediatr Dermatol. 2011;28(4):393-6..
  7. Williams HC. Clinical practice. Atopic dermatitis. N Engl J Med.. 2005;352(22):2314-24.
  8. Wiren K, Nohlgard C, Nyberg F, Holm L, Svensson M, Johannesson A, et al.. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol. 2009;23(11):1267-72.
  9. Castela E, Archier E, Devaux S, Gallini A, Aractingi S, Cribier B, et al.. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol. 2012;26 Suppl .:3:47-51.
Till toppen av sidan